Aspirin Resistance in the Acute Stages of Acute Ischemic Stroke Is Associated with the Development of New Ischemic Lesions

BACKGROUND: Aspirin is a primary antiplatelet agent for the secondary prevention of ischemic stroke. However, if aspirin fails to inhibit platelet function, as is expected in acute ischemic stroke (AIS), it may increase the rate of early clinical events. Therefore, we sought to determine whether asp...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Kim, Joon-Tae, Heo, Suk-Hee, Lee, Ji Sung, Choi, Min-Ji, Choi, Kang-Ho, Nam, Tai-Seung, Lee, Seung-Han, Park, Man-Seok, Kim, Byeong C., Kim, Myeong-Kyu, Cho, Ki-Hyun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2015
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4388531/
https://ncbi.nlm.nih.gov/pubmed/25849632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0120743
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak